First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference BOCA RATON, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference Poster presentations to highlight new quantitative and serologic diagnostic methods for Celiac Disease detection and determination of intestinal mucosal health New tools may serve as companion...

Diet Helps Patients with Celiac Disease Lessen Side Effects and Lose Dangerous Excess Fat with Newly Designed Gluten Free Diet Plans LOS ANGELES, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Celiac disease, an autoimmune disorder caused by gluten intolerance, affects about 1 in 100 Americans and happens when Gliadin, a protein in wheat,...

Diet Doc's Medical Weight Loss Programs Announces Hormone Treatments and Exclusive Diet Pills That Make Following a Gluten Free Diet Easier LOS ANGELES, Aug. 11, 2014 (GLOBE NEWSWIRE) -- With America's increasing awareness of serious weight-related diseases and conditions, including gluten allergies, discovering the key to better health...